- Country: Japan
- Summary: High-speed Sequence Analysis Work for the Treatment Target Search of Ovarian Cancer
- JPT Ref No: 55667325
- Deadline: 12 Aug 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- High-speed sequence analysis task for the purpose of treatment target search of ovarian cancer
Description: Fast Sequence Analysis for Treatment Targets for Ovarian Cancer Targets Purchasing Professional Purchasing Professional Articles Back to List of Purchasing Project Names Ovarian Cancer Development Document Processing Form Publicity Date Tags Deadline Nidgender Date ...
Deadline: 2021-08-12
[Disclaimer: This notification has not been specified for this notification, so it has been added 15 days from a post date. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINHigh-speed Sequence Analysis Work for the Treatment Target Search of Ovarian Cancer - Japan Tender
The NATIONAL RESEARCH AND DEVELOPMENT CORPORATION RIKEN, a Government sector organization in Japan, has announced a new tender for High-speed Sequence Analysis Work for the Treatment Target Search of Ovarian Cancer. This tender is published on JapanTenders under JPT Ref No: 55667325 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-08-12.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
